Patents by Inventor Joseph M. Cummins, Jr.

Joseph M. Cummins, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of immuno-resistant disease with low-dose interferon
    Patent number: 5019382
    Abstract: Neoplastic disease, hyperallergenicity, autoimmune disorders characterized by chronic tissue degenerative inflammation and immuno-resistant viral infections are treated by the administration of interferon at a dosage of about 0.1 to about 5 IU/lb per day by contacting said interferon with oral/pharyngeal mucosa. Interferon is administered in solution or in a novel solid unitary dosage form adapted to be dissolved in saliva when placed in the mouth.
    Type: Grant
    Filed: January 17, 1990
    Date of Patent: May 28, 1991
    Assignee: The Texas A&M University System
    Inventor: Joseph M. Cummins, Jr.
  • Delivery of biologically active components of heterologous species interferon isolates
    Patent number: 4462985
    Abstract: Interferon glycoprotein isolates of heterologous species origin are subjected to treatment in a digestive environment and non-species-specific biologically active fractions thereof are administered, preferably through digestive tract tissue, to the circulatory system of mammals, including humans, to secure antiviral, antiproliferative (e.g., antineoplastic) and immunomodulatory (e.g., immunopotentiating) effects ordinarily associated only with parenteral administration of homologous species interferon.
    Type: Grant
    Filed: September 7, 1982
    Date of Patent: July 31, 1984
    Assignee: University of Illinois Foundation
    Inventor: Joseph M. Cummins, Jr.